NextPlat NXPL
NASDAQ NXPL
$9.13 -0.30 (-3.18%)
At close: Sep 4, 2026 · 4:00 PM EDT

NextPlat (NXPL) Total Non-Current Liabilities (2011 - 2019)

NextPlat's (NXPL) quarterly Total Non-Current Liabilities came in at $1.2 million in Q1 2019, up 15.94% quarter-over-quarter from $1.1 million in Q4 2018.

Analysis

NextPlat (NXPL) Total Non-Current Liabilities (2011 - 2019) Analysis & Trends

NextPlat (NXPL) has reported Total Non-Current Liabilities for 7 consecutive years, with $1.2 million the latest figure, recorded in Q1 2019.

  • On a quarterly basis, Total Non-Current Liabilities changed N/A year-over-year to $1.2 million in Q1 2019; TTM through Mar 2019 was $1.2 million, a N/A change from a year earlier, with the FY2018 full-year figure at $1.1 million, down 12.14% from the prior year.
  • Total Non-Current Liabilities was $1.2 million for Q1 2019 at NextPlat, up from $1.1 million in the prior quarter.
  • Over five years, Total Non-Current Liabilities peaked at $1.3 million in Q3 2017 and troughed at -$750.1 million in Q1 2016.
  • A 5-year average of -$135.5 million and a median of $1.1 million in 2018 frame the typical range for Total Non-Current Liabilities.
  • Across the five-year window, Total Non-Current Liabilities tumbled 36.18% in 2016 and jumped 100.14% in 2017, its largest moves.
  • Over 5 years, Total Non-Current Liabilities stood at $1.1 million in 2015, then plunged by 36.18% to $719380.0 in 2016, then jumped by 67.13% to $1.2 million in 2017, then fell by 12.14% to $1.1 million in 2018, then climbed by 15.94% to $1.2 million in 2019.
  • The last three Total Non-Current Liabilities figures came in at $1.2 million (Q1 2019), $1.1 million (Q4 2018), and $1.2 million (Q4 2017), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Teva Pharmaceutical Industries 42.34 Bn 38.68 Bn 2.15 Bn 16.45 Bn
2 Viatris 19.39 Bn 18.50 Bn 1.46 Bn 18.76 Bn
3 Dr Reddys Laboratories 9.99 Bn 9.85 Bn 396.53 Mn 1.29 Mn
4 Amneal Pharmaceuticals 5.57 Bn 5.53 Bn 334.51 Mn 2.78 Bn
5 Bausch Health Companies 2.45 Bn 1.58 Bn 2.10 Bn 24.86 Bn
6 Ani Pharmaceuticals 1.70 Bn 1.34 Bn 165.89 Mn 881.37 Mn
7 Alvotech 1.66 Bn 1.52 Bn 2.56 Mn 1.45 Bn
8 Amphastar Pharmaceuticals 985.90 Mn 695.77 Mn 93.47 Mn 946.17 Mn
9 Fennec Pharmaceuticals 434.07 Mn 392.82 Mn 17.15 Mn 20.92 Mn
10 NextPlat 24.77 Mn 12.93 Mn 4.69 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2019 1.22 Mn
Dec 31, 2018 1.06 Mn
Dec 31, 2017 1.20 Mn
Sep 30, 2017 1.29 Mn
Jun 30, 2017 1.07 Mn
Mar 31, 2017 1.04 Mn
Dec 31, 2016 719,380.00
Sep 30, 2016 966,031.00
Jun 30, 2016 -750.00 Mn
Mar 31, 2016 -750.11 Mn
Dec 31, 2015 1.13 Mn
Dec 31, 2012 1.66 Mn
Sep 30, 2012 1.48 Mn
Jun 30, 2012 1.14 Mn
Dec 31, 2011 688,764.00